In vitro characterization of stem cell-like properties of drug-resistant colon cancer subline

Oncology Research

Volumn 21, Issue 1, 2013, Pages 51-57

  Yang, Dong ^a,b   Wang, Haijuan ^a   Zhang, Jinlong ^b   Li, Chunxiao ^a   Lu, Zhong ^b   Liu, Jin ^b   Lin, Chen ^a   Li, Guixin ^b   Qian, Haili ^a,b  

^a CANCER HOSPITAL   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

ATP binding cassette superfamily G member 2 (ABCG2); Drug resistant cells; Octamer binding transcription factor 4 (OCT4); Oxaliplatin; SRY related HMG box containing transcription factor 2 (SOX2)

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; OXALIPLATIN; PACLITAXEL; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CELL ADHESION; CELL CLONE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL INVASION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; HCT116 CELLS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; ORGANOPLATINUM COMPOUNDS;

EID: 84890900434     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504013X13793555706768     Document Type: Article

References (20)

1. Saikawa, Y.; Fukuda, K.; Takahashi, T.; Nakamura, R.; Takeuchi, H.; Kitagawa, Y. Gastric carcinogenesis and the cancer stem cell hypothesis. Gastric Cancer 13:11-24; 2010.
2. Takebe, N.; Harris, P. J.; Warren, R. Q.; Ivy, S. P. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Clin. Oncol. 8:97-106; 2011.
3. Vermeulen, L.; Sprick, M. R.; Kemper, K.; Stassi, G.; Medema, J. P. Cancer stem cells - Old concepts, new insights. Cell Death Differ. 15:947-958; 2008.
4. Zhong, Y.; Guan, K.; Zhou, C.; Ma, W.; Wang, D.; Zhang, Y.; Zhang, S. Cancer stem cells sustaining the growth of mouse melanoma are not rare. Cancer Lett. 292:17-23; 2010.
5. Perona, R.; Lopez-Ayllon, B. D.; de Castro, Carpeno, J; Belda-Iniesta, C. A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer. Clin. Transl. Oncol. 13:289-293; 2011.
6. Maeno, Y.; Nakazawa, S.; Yamamoto, N.; Shinzato, M.; Nagashima, S.; Tanaka, K.; Sasaki, J.; Rittling, S. R.; Denhardt, D. T.; Uede, T.; Taniguchi, K. Osteopontin participates in Th1-mediated host resistance against nonlethal malaria parasite Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 74:2423-2427; 2006.
7. Kawano, Y.; Kypta, R. Secreted antagonists of the Wnt signalling pathway. J. Cell. Sci. 116:2627-2634; 2003.
8. Wu, C. P.; Hsieh, C. H.; Wu, Y. S. The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy. Mol. Pharm. 8:1996-2011; 2011.
9. Voland, C.; Bord, A.; Peleraux, A.; Penarier, G.; Carriere, D.; Galiegue, S.; Cvitkovic, E.; Jbilo, O.; Casellas, P. Repression of cell cycle-related proteins by oxaliplatin but not cisplatin in human colon cancer cells. Mol. Cancer Ther. 5:2149-2157; 2006.
10. Jin, J.; Huang, M.; Wei, H. L.; Liu, G. T. Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel(7402). World. J. Gastroenterol. 8:1029-1034; 2002.
11. Ishikawa, F.; Yoshida, S.; Saito, Y.; Hijikata, A.; Kitamura, H.; Tanaka, S.; Nakamura, R.; Tanaka, T.; Tomiyama, H.; Saito, N.; Fukata, M.; Miyamoto, T.; Lyons, B.; Ohshima, K.; Uchida, N.; Taniguchi, S.; Ohara, O.; Akashi, K.; Harada, M.; Shultz, L. D. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat. Biotechnol. 25:1315-1321; 2007.
12. Schwartz, S. M., Murry, C. E. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu. Rev. Med. 49:437-460; 1998.
13. Nelson, T. J.; Martinez-Fernandez, A.; Terzic, A. Induced pluripotent stem cells: developmental biology to regenerative medicine. Nat. Rev. Cardiol. 7:700-710; 2010.
14. Boumendjel, A.; Macalou, S.; Valdameri, G.; Pozza, A.; Gauthier, C.; Arnaud, O.; Nicolle, E.; Magnard, S.; Falson, P.; Terreux, R.; Carrupt, P. A.; Payen, L.; Di, P. A. Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation. Curr. Med. Chem. 18:3387-3401; 2011.
15. Sarkadi, B.; Homolya, L.; Szakacs, G.; Varadi, A. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol. Rev. 86:1179-1236; 2006.
16. Vlaming, M. L.; Lagas, J. S.; Schinkel, A. H. Physiological and pharmacological roles of ABCG2 (BCRP): Recent findings in Abcg2 knockout mice. Adv. Drug Deliv. Rev. 61:14-25; 2009.
17. Islam, M. O.; Kanemura, Y.; Tajria, J.; Mori, H.; Kobayashi, S.; Hara, M.; Yamasaki, M.; Okano, H.; Miyake, J. Functional expression of ABCG2 transporter in human neural stem/progenitor cells. Neurosci. Res. 52:75-82; 2005.
18. Watanabe, K.; Nishida, K.; Yamato, M.; Umemoto, T.; Sumide, T.; Yamamoto, K.; Maeda, N.; Watanabe, H.; Okano, T.; Tano, Y. Human limbal epithelium contains side population cells expressing the ATP-binding cassette transporter ABCG2. FEBS Lett. 565:6-10; 2004.
19. Scharenberg, C. W.; Harkey, M. A.; Torok-Storb, B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99:507-512; 2002.
20. Apati, A.; Orban, T. I.; Varga, N.; Nemeth, A.; Schamberger A.; Krizsik V.; Erdelyi-Belle B.; Homolya L.; Varady G.; Padanyi R.; Karaszi E.; Kemna E. W.; Nemet K.; Sarkadi B. High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochem. Biophys. Acta 1778:2700-2709; 2008.